Patent details

Basic Information

Publication number:

EP3075394

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP161657366

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT FOR NEOPLASTIC DISEASES

French Title of Invention:

TRAITEMENT DE MALADIES NÉOPLASIQUES

German Title of Invention:

BEHANDLUNG VON NEOPLASIEERKRANKUNGEN

SPC Number:

Dates

Filing date:

23/08/2011

Grant date:

28/11/2018

EP Publication Date:

05/10/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/11/2018

EP B1 Publication Date:

28/11/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

23/08/2019

Expiration date:

23/08/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/11/2018

 

 

Name:

XBiotech, Inc

Address:

1055 West Hastings Street, Suite 300, Vancouver, British Columbia V6E 2E9, Canada (CA)

Inventor

Name:

Simard, John

Address:

United States (US)

Priority

1

Priority Number:

376097 P

Priority Date:

23/08/2010

Priority Country:

United States (US)

2

Priority Number:

406759 P

Priority Date:

26/10/2010

Priority Country:

United States (US)

3

Priority Number:

411183 P

Priority Date:

08/11/2010

Priority Country:

United States (US)

4

Priority Number:

201161480635 P

Priority Date:

29/04/2011

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/00; C07K 16/24;

Publication

European Patent Bulletin

Issue number:

201848

Publication date:

28/11/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages